Rainbow Children's Medicare Limited has announced that its Board of Directors will convene on January 28, 2026, to consider and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting will review both standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The company has formally notified both the National Stock Exchange of India Limited (Symbol: RAINBOW) and BSE Limited (Scrip Code: 543524) about the scheduled board meeting in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Status

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code for Prevention of Insider Trading, the trading window for dealing in Rainbow Children's Medicare Limited securities is currently closed. The trading window will reopen 48 hours after the declaration of the financial results. This closure was initially communicated to the exchanges on December 27, 2025.

Company Information

Rainbow Children's Medicare Limited operates as a specialized healthcare provider focusing on pediatric and maternity care. The company has established its presence across multiple cities including Bengaluru, Chennai, Delhi, Hyderabad, Vijayawada, Visakhapatnam, and Warangal. The company's registered office is located at Banjara Hills, Hyderabad, Telangana.

Regulatory Compliance

The notification was signed by Shreya Mitra, Company Secretary and Compliance Officer, on January 21, 2026. The company maintains transparency in its corporate governance practices by promptly informing stakeholders about significant corporate developments and adhering to regulatory requirements for listed entities.